AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-80
Results: 1-25/80
PRIMARY SCLEROSING CHOLANGITIS
Authors: JAHN HU JOPKE F LOBECK H WEINKE T
Citation: Hu. Jahn et al., PRIMARY SCLEROSING CHOLANGITIS, Deutsche Medizinische Wochenschrift, 123(43), 1998, pp. 1281-1284
EFFECTIVE THERAPY FOR HEPATIC OSLER,M. WITH SYSTEMIC HYPERCIRCULATIONBY LIGATION OF THE HEPATIC-ARTERY AND SUBSEQUENT LIVER-TRANSPLANTATION
Authors: NEUMANN UP KNOOP M LANGREHR JM KECK H BECHSTEIN WO LOBECK H VOGEL T NEUHAUS P
Citation: Up. Neumann et al., EFFECTIVE THERAPY FOR HEPATIC OSLER,M. WITH SYSTEMIC HYPERCIRCULATIONBY LIGATION OF THE HEPATIC-ARTERY AND SUBSEQUENT LIVER-TRANSPLANTATION, Transplant international, 11(4), 1998, pp. 323-326
COMPLETE RECOVERY OF RENAL-FUNCTION IN A DIALYSIS-DEPENDENT PATIENT WITH GOODPASTURE-SYNDROME
Authors: SCHINDLER R KAHL A LOBECK H BERWECK S KAMPF D FREI U
Citation: R. Schindler et al., COMPLETE RECOVERY OF RENAL-FUNCTION IN A DIALYSIS-DEPENDENT PATIENT WITH GOODPASTURE-SYNDROME, Nephrology, dialysis, transplantation, 13(2), 1998, pp. 462-466
A RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY FOR IMMUNOSUPPRESSIVE INDUCTION THERAPY AFTER LIVER-TRANSPLANTATION
Authors: LANGREHR JM GLANEMANN M GUCKELBERGER O KLUPP J NEUMANN U MACHENS C LOHMANN R KNOOP M LOBECK H SCHLAG H KECK H SETTMACHER U BECHSTEIN WO NEUHAUS PJ
Citation: Jm. Langrehr et al., A RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY FOR IMMUNOSUPPRESSIVE INDUCTION THERAPY AFTER LIVER-TRANSPLANTATION, Clinical transplantation, 12(4), 1998, pp. 303-312
LONG-TERM EFFICACY OF INTERFERON-ALPHA TREATMENT IN CHRONIC HEPATITIS-C
Authors: BERG T KAUL T HEUFT HG NAUMANN U LOBECK H WIEDENMANN B HOPF U
Citation: T. Berg et al., LONG-TERM EFFICACY OF INTERFERON-ALPHA TREATMENT IN CHRONIC HEPATITIS-C, Journal of hepatology, 29(3), 1998, pp. 511-512
P53 MUTAGENESIS IN KLATSKIN TUMORS
Authors: JONAS S SPRINGMEIER G TAUBER R WIEDENMANN B LOBECK H GESSNER R KREFT B KLING N MOELLING K NEUHAUS P
Citation: S. Jonas et al., P53 MUTAGENESIS IN KLATSKIN TUMORS, Human pathology, 29(9), 1998, pp. 955-960
EXTRACELLULAR-MATRIX - AN EARLY TARGET OF PRESERVATION REPERFUSION INJURY AND ACUTE REJECTION AFTER SMALL-BOWEL TRANSPLANTATION/
Authors: MUELLER AR PLATZ KP HECKERT C HAUSLER M GUCKELBERGER O SCHUPPAN D LOBECK H NEUHAUS P
Citation: Ar. Mueller et al., EXTRACELLULAR-MATRIX - AN EARLY TARGET OF PRESERVATION REPERFUSION INJURY AND ACUTE REJECTION AFTER SMALL-BOWEL TRANSPLANTATION/, Transplantation proceedings, 30(6), 1998, pp. 2569-2571
DIFFERENTIATION BETWEEN PRESERVATION REPERFUSION INJURY AND ACUTE REJECTION AFTER SMALL-BOWEL TRANSPLANTATION
Authors: MUELLER AR PLATZ KP HECKERT C HAUSLER M SCHUPPAN D LOBECK H NEUHAUS P
Citation: Ar. Mueller et al., DIFFERENTIATION BETWEEN PRESERVATION REPERFUSION INJURY AND ACUTE REJECTION AFTER SMALL-BOWEL TRANSPLANTATION, Transplantation proceedings, 30(6), 1998, pp. 2657-2659
NITRIC-OXIDE PRODUCTION AFTER SYNGENEIC AND ALLOGENEIC SMALL-BOWEL TRANSPLANTATION
Authors: PLATZ KP MUELLER AR HECKERT C HAUSLER M GUCKELBERGER O LOBECK H NEUHAUS P
Citation: Kp. Platz et al., NITRIC-OXIDE PRODUCTION AFTER SYNGENEIC AND ALLOGENEIC SMALL-BOWEL TRANSPLANTATION, Transplantation proceedings, 30(6), 1998, pp. 2662-2664
ANTI-IL-2 RECEPTOR BT563 VERSUS PLACEBO - A RANDOMIZED TRIAL FOR INDUCTION THERAPY AFTER LIVER-TRANSPLANTATION
Authors: GLANEMANN M LANGREHR JM RAAKOW R GUCKELBERGER O LOHMANN R KLUPP J LOBECK H SCHLAG H KECK H BECHSTEIN WO SETTMACHER U NEUHAUS P
Citation: M. Glanemann et al., ANTI-IL-2 RECEPTOR BT563 VERSUS PLACEBO - A RANDOMIZED TRIAL FOR INDUCTION THERAPY AFTER LIVER-TRANSPLANTATION, Transplantation proceedings, 30(5), 1998, pp. 2159-2160
FK506 FOR PRIMARY AND RESCUE THERAPY FOLLOWING LIVER-TRANSPLANTATION
Authors: PLATZ KP MUELLER AR ZYTOWSKI M LOBECK H NEUHAUS P
Citation: Kp. Platz et al., FK506 FOR PRIMARY AND RESCUE THERAPY FOLLOWING LIVER-TRANSPLANTATION, Transplantation proceedings, 30(4), 1998, pp. 1409-1410
RISK AND BENEFIT OF ANTIBODY INDUCTION THERAPY IN COMBINATION WITH TACROLIMUS IMMUNOSUPPRESSION AFTER LIVER-TRANSPLANTATION
Authors: KLUPP J BECHSTEIN WO PRATSCHKE J TULLIUS SG GEBHARD A LOBECK H LANGREHR JM NEUHAUS R NEUHAUS P
Citation: J. Klupp et al., RISK AND BENEFIT OF ANTIBODY INDUCTION THERAPY IN COMBINATION WITH TACROLIMUS IMMUNOSUPPRESSION AFTER LIVER-TRANSPLANTATION, Transplantation proceedings, 30(4), 1998, pp. 1443-1444
A RANDOMIZED TRIAL COMPARING ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY ANDPLACEBO FOR IMMUNOSUPPRESSIVE THERAPY AFTER OLT
Authors: LANGREHR JM GLANEMANN M SCHNELLER A NEUMANN U GUCKELBERGER O LOHMANN R KLUPP J JONAS S KNOOP M LOBECK H SCHLAG H KECK H SETTMACHER U BECHSTEIN WO NEUHAUS PJ
Citation: Jm. Langrehr et al., A RANDOMIZED TRIAL COMPARING ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY ANDPLACEBO FOR IMMUNOSUPPRESSIVE THERAPY AFTER OLT, Transplantation proceedings, 30(4), 1998, pp. 1445-1446
DOES INITIAL GRAFT FUNCTION INFLUENCE THE OUTCOME AFTER LIVER-TRANSPLANTATION
Authors: MUELLER AR PLATZ KP KRAUSE P NEUHAUS R LOBECK H NEUHAUS P
Citation: Ar. Mueller et al., DOES INITIAL GRAFT FUNCTION INFLUENCE THE OUTCOME AFTER LIVER-TRANSPLANTATION, Transplantation proceedings, 30(4), 1998, pp. 1464-1465
INDICATIONS FOR MYCOPHENOLATE MOFETIL THERAPY IN HEPATITIS-C PATIENTSUNDERGOING LIVER-TRANSPLANTATION
Authors: PLATZ KP MUELLER AR WILLIMSKI C MANSOORIAN B BERG T NEUHAUS R HOPF U LOBECK H NEUHAUS P
Citation: Kp. Platz et al., INDICATIONS FOR MYCOPHENOLATE MOFETIL THERAPY IN HEPATITIS-C PATIENTSUNDERGOING LIVER-TRANSPLANTATION, Transplantation proceedings, 30(4), 1998, pp. 1468-1469
INFLUENCE OF IMMUNOSUPPRESSION ON PATIENT OUTCOME AFTER LIVER-TRANSPLANTATION
Authors: MUELLER AR PLATZ KP WILLIMSKI C BERG T NEUHAUS R LOBECK H NEUHAUS P
Citation: Ar. Mueller et al., INFLUENCE OF IMMUNOSUPPRESSION ON PATIENT OUTCOME AFTER LIVER-TRANSPLANTATION, Transplantation proceedings, 30(4), 1998, pp. 1495-1496
PRETRANSPLANT VIROLOGICAL MARKERS HEPATITIS-C VIRUS GENOTYPE AND VIREMIA LEVEL ARE NOT HELPFUL IN PREDICTING INDIVIDUAL OUTCOME AFTER ORTHOTOPIC LIVER-TRANSPLANTATION
Authors: BERG T HOPF U BECHSTEIN WO MULLER AR FUKUMOTO T NEUHAUS R LOBECK H NEUHAUS P
Citation: T. Berg et al., PRETRANSPLANT VIROLOGICAL MARKERS HEPATITIS-C VIRUS GENOTYPE AND VIREMIA LEVEL ARE NOT HELPFUL IN PREDICTING INDIVIDUAL OUTCOME AFTER ORTHOTOPIC LIVER-TRANSPLANTATION, Transplantation, 66(2), 1998, pp. 225-228
THE EXTRACELLULAR-MATRIX - AN EARLY TARGET OF PRESERVATION REPERFUSION INJURY AND ACUTE REJECTION AFTER SMALL-BOWEL TRANSPLANTATION/
Authors: MUELLER AR PLATZ KP HECKERT C HAUSLER M GUCKELBERGER O SCHUPPAN D LOBECK H NEUHAUS P
Citation: Ar. Mueller et al., THE EXTRACELLULAR-MATRIX - AN EARLY TARGET OF PRESERVATION REPERFUSION INJURY AND ACUTE REJECTION AFTER SMALL-BOWEL TRANSPLANTATION/, Transplantation, 65(6), 1998, pp. 770-776
BIPHASIC SPIRAL COMPUTED-TOMOGRAPHY FOR DETECTION OF HEPATOCELLULAR-CARCINOMA BEFORE RESECTION OR ORTHOTOPIC LIVER-TRANSPLANTATION
Authors: HANNINEN EL VOGL TJ BECHSTEIN WO GUCKELBERGER O NEUHAUS P LOBECK H FELIX R
Citation: El. Hanninen et al., BIPHASIC SPIRAL COMPUTED-TOMOGRAPHY FOR DETECTION OF HEPATOCELLULAR-CARCINOMA BEFORE RESECTION OR ORTHOTOPIC LIVER-TRANSPLANTATION, Investigative radiology, 33(4), 1998, pp. 216-221
MYOEPITHELIAL CARCINOMA (MALIGNANT MYOEPI THELIOMA) OF THE SALIVARY-GLANDS - A CASE-REPORT
Authors: HAISCH A KNOBBER D LOBECK H
Citation: A. Haisch et al., MYOEPITHELIAL CARCINOMA (MALIGNANT MYOEPI THELIOMA) OF THE SALIVARY-GLANDS - A CASE-REPORT, HNO. Hals-, Nasen-, Ohrenarzte, 46(1), 1998, pp. 66-69
STENOSIS OF THE TERMINAL ILEUM - ENDOMETR IOSIS IN THE DIFFERENTIAL-DIAGNOSIS OF CROHNS-DISEASE
Authors: KORBER J GRAMMEL S LOBECK H WEIDEMANN H
Citation: J. Korber et al., STENOSIS OF THE TERMINAL ILEUM - ENDOMETR IOSIS IN THE DIFFERENTIAL-DIAGNOSIS OF CROHNS-DISEASE, Deutsche Medizinische Wochenschrift, 122(30), 1997, pp. 926-929
P53 HOT-SPOT MUTATIONAL ANALYSIS IN ADVANCED WESTERN GALLBLADDER CARCINOMA
Authors: JONAS S SPRINGMEIER G TAUBER R WIEDENMANN B GESSNER R KLING N LOBECK H FIEGER C BECHSTEIN WO NEUHAUS P
Citation: S. Jonas et al., P53 HOT-SPOT MUTATIONAL ANALYSIS IN ADVANCED WESTERN GALLBLADDER CARCINOMA, World journal of surgery, 21(7), 1997, pp. 768-772
FIBROSING CHOLESTATIC HEPATITIS (FCH) AND MUTATIONS IN THE PRES-GENOME OF THE HEPATITIS-B VIRUS AFTER LIVER-TRANSPLANTATION
Authors: SCHREM H LEDER K LANDT O BECHSTEIN WO TRAUTWEIN C HOPF U LOBECK H NEUHAUS P
Citation: H. Schrem et al., FIBROSING CHOLESTATIC HEPATITIS (FCH) AND MUTATIONS IN THE PRES-GENOME OF THE HEPATITIS-B VIRUS AFTER LIVER-TRANSPLANTATION, Hepatology, 26(4), 1997, pp. 747-747
LONG-TERM EFFICACY OF INTERFERON IN CHRONIC HEPATITIS-C
Authors: BERG T KAUL T HEUFT HG NAUMANN U LOBECK H HOPF U
Citation: T. Berg et al., LONG-TERM EFFICACY OF INTERFERON IN CHRONIC HEPATITIS-C, Hepatology, 26(4), 1997, pp. 1178-1178
A PRETRANSPLANT INFECTION WITH PRECORE MUTANTS OF HEPATITIS-B VIRUS DOES NOT INFLUENCE THE OUTCOME OF ORTHOTOPIC LIVER-TRANSPLANTATION IN PATIENTS ON HIGH-DOSE ANTI-HEPATITIS-B VIRUS SURFACE-ANTIGEN IMMUNOPROPHYLAXIS
Authors: NAUMANN U PROTZERKNOLLE U BERG T LEDER K LOBECK H BECHSTEIN WO GERKEN G HOPF U NEUHAUS P
Citation: U. Naumann et al., A PRETRANSPLANT INFECTION WITH PRECORE MUTANTS OF HEPATITIS-B VIRUS DOES NOT INFLUENCE THE OUTCOME OF ORTHOTOPIC LIVER-TRANSPLANTATION IN PATIENTS ON HIGH-DOSE ANTI-HEPATITIS-B VIRUS SURFACE-ANTIGEN IMMUNOPROPHYLAXIS, Hepatology, 26(2), 1997, pp. 478-484
Risultati: 1-25 | 26-50 | 51-75 | 76-80